Related Articles
THE EFFECT OF LOW-DOSE OKT3 MONOCLONAL-ANTIBODY THERAPY ON K562 CYTOTOXICITY IN HUMAN CANCER-PATIENTS
THE TREATMENT OF COLORECTAL HEPATIC METASTASES BY CONTINUOUS LOCAL INFUSION OF INTERLEUKIN-2
Large scale ex vivo expansion of clinical‑grade effector cells for adoptive immunotherapy
SUBCUTANEOUS RIL-2 IN ADVANCED MELANOMA AND KIDNEY CARCINOMA
EFFECTS OF SUBCUTANEOUS RECOMBINANT IL-2 ON HUMORAL IMMUNITY IN ADVANCED CANCER-PATIENTS